Home › Funds › Migdal Insurance & Financial Holdings Ltd. › ABBV

Migdal Insurance & Financial Holdings Ltd. position in ABBV

ABBVIE INC · Health Care

Migdal Insurance & Financial Holdings Ltd. reported holding 562,561 shares of ABBV (ABBVIE INC) in its Q2 2026 13F filing — a position valued at US$141.6M, representing 0.91% of its reported portfolio and ranking #30 among its reported holdings. Migdal Insurance & Financial Holdings Ltd. has disclosed ABBV holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)562.56K sh
Reported value held$141.56M
Portfolio Weight0.91%
First reportedQ3 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Migdal Insurance & Financial Holdings Ltd.'s ABBV position evolved

Migdal Insurance & Financial Holdings Ltd. first disclosed a stake in ABBV in Q3 2023 at 3,443 shares (US$518K). The position peaked in Q2 2026 at 562,561 shares, worth US$141.6M. Across 12 filings, Migdal Insurance & Financial Holdings Ltd. increased the stake 6 time(s), trimmed it 5 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 562,561 shares valued at US$141.6M — an increase of 150,409 shares quarter over quarter.. Notable position changes include a 223% increase in Q4 2023 (shares rose 19% over the following quarter), a 24444% increase in Q2 2025 (shares rose 26% over the following quarter), a 97% increase in Q3 2025 (shares were roughly flat over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 3.44K $518.00K New
Q4 2023 11.10K $1.72M Add
Q1 2024 3.42K $623.00K Reduce
Q2 2024 2.55K $436.00K Reduce
Q3 2024 2.36K $466.00K Reduce
Q4 2024 2.04K $362.00K Reduce
Q1 2025 532 $111.00K Reduce
Q2 2025 130.57K $24.24M Add
Q3 2025 256.60K $59.41M Add
Q4 2025 331.70K $75.79M Add
Q1 2026 412.15K $89.64M Add
Q2 2026 562.56K $141.56M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABBV and 13F data

ABBV (ABBVIE INC) is a Health Care company. 35 other funds we track also report a position in ABBV — the largest reported positions include Vanguard Group (US$41.31B), BlackRock Inc (US$37.62B), VANGUARD CAPITAL MANAGEMENT LLC (US$29.04B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABBV

All ABBV fund holders →

FAQ

How long has Migdal Insurance & Financial Holdings Ltd. held ABBV?

Migdal Insurance & Financial Holdings Ltd. has disclosed ABBV holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is Migdal Insurance & Financial Holdings Ltd.'s current position in ABBV?

As of Q2 2026, Migdal Insurance & Financial Holdings Ltd. holds 562.56K shares of ABBV (ABBVIE INC), valued at $141.56M, representing 0.91% of its reported portfolio and ranking #30.

Has Migdal Insurance & Financial Holdings Ltd. been buying or selling ABBV?

In the latest 13F filing (Q2 2026), Migdal Insurance & Financial Holdings Ltd. increased its position in ABBV. The position peaked in Q2 2026 at 562.56K shares.

Which other funds hold ABBV?

Other major institutional holders of ABBV include Vanguard Group, BlackRock Inc, VANGUARD CAPITAL MANAGEMENT LLC, among 35 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.